Rb. Surana et al., CONSTITUTIONAL HETEROMORPHISM OF 9Q13-]Q21 IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA, Clinical genetics, 47(6), 1995, pp. 321-323
Cytogenetic studies were carried out in a 44-year-old white male becau
se of newly diagnosed chronic myelogenous leukemia. His initial bone m
arrow study revealed 46,XY,var(9)(q13 --> q21)/46,XY,var(9) (q13 --> q
21), t(9;22)(q34;q11) karyotypes and later he also acquired a 47,XY,8,var(9)(q13 --> q21), t(9;22)(q34;q11) clone. The var(9)(q13 --> q21)
heteromorphism was observed in the normal 9 homolog, in 200 GTG-bande
d bone marrow metaphases in seven cytogenetic studies (1988-90). This
heteromorphism was observed in the normal cell line, in the two chroni
c myelogenous leukemia-related clones, as well as in 100 mitogen-induc
ed peripheral blood lymphocytes, indicating its constitutional nature.
This seems to be the first report of var(9)(q13 --> q21) heteromorphi
sm, involving GTG-positive euchromatic band, in a chronic myelogenous
leukemia proband.